Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Euglycaemic clamp  (2)
  • Obesity  (2)
  • Secretin  (2)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 66 (1988), S. 216-222 
    ISSN: 1432-1440
    Keywords: Fat distribution ; Hyperinsulinemia ; Obesity ; Glucose tolerance ; Non-insulin dependent diabetes
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Relationship between body fat distribution, serum insulin, and glucose tolerance in obese, non-diabetic women. Recent studies suggest that hyperinsulinemia and upper body obesity are predictive factors for the development of non-insulindependent diabetes mellitus. To further characterize the relationship between body fat distribution, serum insulin, and glucose tolerance an oral glucose tolerance test was performed in 48 obese, nondiabetic women. Fasting insulin levels were correlated to both total body fat calculated as body mass index (r=0.58,p〈0.001) and upper body fat distribution expressed as waist-to-hip ratio (WHR,r=0.47,p〈0.01). In the women with upper body fat localization (WHR〉0.90) significantly higher basal and glucose-stimulated insulin concentrations were established than in the women with a lower body type of obesity (WHR〈0.78) (basal insulin 27.4±11.5 vs. 15.4±8.8 mU/l,p〈0.05, insulin area 779±320 vs. 468±237 U,p〈0.05). They also had impaired glucose tolerance (glucose area 925±139 vs. 633±147 U,p〈0.01). Fasting triglyceride concentrations were correlated both with WHR (r=0.63,p〈0.001) and fasting insulin (r=0.33,p〈0.05) but not with BMI (r=−0.02, n.s.). A positive association was found between systolic and diastolic blood pressure and both WHR (r=0.43 andr=0.44 resp.,p〈0.01) and BMI (eachr=0.35,p〈0.05). Interestingly, basal insulin was also associated with blood pressure (r=0.30,p〈0.1, andr=0.40,p〈0.01 resp.). These results suggest a close relationship between upper body obesity, hyperinsulinemia, and impaired glucose tolerance. Women with an upper body tpye of obesity also show tendencies to hypertriglyceridemia and hypertension. Obese women with upper body obesity represent a subgroup of the obesity population with an increased risk to develop type-II diabetes.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1440
    Keywords: Coronary artery disease ; Sex hormones ; Obesity ; Body fat distribution ; Angiography
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The relationship between circulating sex hormone levels and the occurrence of coronary artery disease (CAD) was studied in a group of 274 men undergoing coronary angiography. Hormone levels in men with CAD (n=200) were compared to those in men found to be free of coronary lesions (n=74). No significant differences were found for serum concentrations of estradiol, total testosterone, sex-hormone-binding globulin, free androgen index, dehydroepiandrosterone sulfate, or cortisol between the two groups. Serum androgens were negatively correlated to age in both groups, whereas estradiol was weakly associated with total cholesterol in the group of men without CAD. No consistent associations were detected between sex hormone levels and the degree of obesity or the distribution of body fat, the latter being assessed by the ratio of waist-to-hip circumferences. The results of this study do not support a significant role of sex steroid hormones in coronary artery disease in men.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 63 (1985), S. 545-553 
    ISSN: 1432-1440
    Keywords: Type I diabetes ; Insulin resistance ; Euglycaemic clamp ; Insulin receptor binding ; Insulin antibodies
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Insulin sensitivity was assessed using the euglycaemic clamp technique in eight type I diabetic patients (after overnight blood glucose normalization with an artificial pancreas) and in six healthy subjects. Basal insulin concentrations were higher in diabetic patients (25±4 µU/ml) than in control subjects (17±1 µU/ml;P〈0.05). Insulin infusion of 0.5, 1.0, 2.0 and 5.0 mU/kg per min during subsequent 2-h periods resulted in similar mean steady-state insulin concentrations in both groups. The mean dextrose requirements during the last 40 min of each period were nevertheless decreased in diabetic patients (1.6±0.5, 3.5±0.8, 6.5±0.7, 10.2±0.7 mg/kg per min) as compared with control subjects (4.7±0.3, 8.2±0.9, 10.2±0.9, 12.4±0.9 mg/kg per min). At low insulin concentrations dextrose requirements were diminished in all diabetic subjects. At the highest insulin levels, individual dose-response curves from only four patients were within the normal range. Under basal conditions, the monocyte receptor number was significantly reduced in diabetic patients (17,500±2,800 sites/cell) as compared with control subjects (26,700±2,500 sites/cell;P〈0.05), whereas there were no differences regarding empty site affinities. Receptor data did not differ in patients with normal and decreased maximal dextrose requirements. Insulin resistance is apparently a common feature of type I diabetes at serum insulin concentrations of approximately 100 µU/ml. Normalization of the insulin effect by higher insulin concentrations is not possible in all patients. Insulin antibodies at concentrations observed in this study (〈0.16 mU/ml) do not contribute significantly to insulin resistance; receptor and postreceptor defects are possibly more important.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1432-1440
    Keywords: Semisynthetic human insulin ; Biological potency ; Insulin hypoglycaemia ; Euglycaemic clamp
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The biological potency of semisynthetic human insulin (Actrapid HM, Novo) and purified pork insulin (Actrapid MC, Novo) was assessed in normal and diabetic subjects. The blood glucose lowering effect and the related counter-regulatory response were initially tested in six healthy subjects who received an i.v. injection of 0.15 U/kg body weight of either insulin preparation. The attained insulin levels were very similar (peak at 15 min: HM 139±7, MC 129±7 µU/ml), as well as the resulting blood glucose curves. A prolonged suppression of C-peptide values was observed after injecting both preparations. The evoked counter-regulatory response [glucagon, growth hormone (GH), cortisol and catecholamines] showed minimal differences. Prolactin secretion was almost identical after HM and MC injection. A glucose clamp study was subsequently performed in six insulin-dependent diabetic (IDD) patients. Blood glucose levels were maintained at 80 mg/dl by the artificial pancreas during a 180 min infusion of MC or HM insulin (30 mU/kg/h). The amounts of dextrose infused during the last 60 min of the study were not significantly different (121±14 vs 137±11 mg/kg/h for MC and HM, respectively). It is clear from our results that at the dose levels used in this study, the biological potency of i.v. injected HM is very similar to that of MC.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1433-8580
    Keywords: Secretin ; Cholecystokinin-Pancreozymin ; Intestinal hormones ; Intestinal absorption
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The effects of natural secretin (90%) and synthetic secretin as well as impure (10%) and pure (99%) cholecystokinin-pancreozymin (CCK) on net absorption of water, electrolytes, and glucose in human jejunum were studied in 31 normal subjects. An intestinal perfusion technique with a triple-lumen tube was used. Net absorption of water and solute was significantly inhibited by both hormones only with larger doses, pure CCK being less active than impure CCK. A dose-dependent response of water and electrolyte absorption to graded doses of pure CCK was observed, without concomitant inhibition of glucose absorption with lower doses. The findings suggest that secretin and CCK may not be of physiologic importance regarding intestinal absorption in man. The definite changes in intestinal motility and transit rate caused by these hormones seem more likely to result in a reduction of intestinal absorption and an increase in the secretion of water and electrolytes along the proximal small bowel.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1432-0428
    Keywords: Secretin ; pancreozymin ; exocrine pancreatic insufficiency ; insulin ; free fatty acids ; glucose
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Résumé L'effet des hormones intestinales sécrétine et pancréozymine sur la sécrétion d'insuline, sur la glycémie, les acides gras et le glycérol a été étudié chez onze malades sans diabète mais ayant une insuffisance pancréatique exocrine d'après des résultats cliniques et chimiques. Un groupe de 30 sujets normaux a été utilisé comme témoins. Les hormones intestinales n'ont causé aucune augmentation d'insuline dans le sérum des malades ayant une insuffisance pancréatique exocrine. La sécrétion d'insuline après l'injection intraveineuse de glucose était normale. Il semble que la présence du tissu exocrine du pancréas soit nécessaire pour obtenir une stimulation de la sécrétion d'insuline par la sécrétine et la pancréozymine. Comme il était prévu, il n'y a pas eu chez ces malades — contrairement à ce qui se passe chez les personnes normales — de sécrétion d'insuline différente après l'application de glucose oral et intraveineux. Ces résultats montrent que la similitude des modifications de l'insuline plasmatique après administration de glucose par voie orale et parentérale peut signifier un mauvais fonctionnement du pancréas exocrine. On peut en déduire qu'un récepteur du glucose de la cellule bêta ou de la membrane superficielle peut opérer indépendamment du tissu pancréatique exocrine et des hormones intestinales. D'autre part, il est proposé comme conclusion qu'un «entérorécepteur» de la cellule bêta est sensible à l'action des hormones intestinales et qu'il est dépendant, plus ou moins, d'un tissu pancréatique exocrine.
    Abstract: Zusammenfassung Bei 11 nicht-diabetischen Patienten mit klinisch und laborchemisch nachgewiesener chronischer exkretorischen Pankreasinsuffizienz wurde die Wirkung der intestinalen Hormone Sekretin und Pankreozymin auf die Insulinsekretion, den Blutzucker, die freien Fettsäuren und das Glycerin untersucht und verglichen mit den an 30 normalen Versuchspersonen gewonnenen Befunden. — Bei den Patienten mit exkretorischer Pankreasinsuffizienz bewirkten die oben genannten intestinalen Hormone keine Erhöhung des Seruminsulins, obwohl die Insulinsekretion nach der i.v. Verabreichung von Glucose nicht beeinträchtigt war. Offensichtlich ist für eine Insulinausschüttung nach Sekretin und Pankreozymin beim Menschen ein intaktes exkretorisches Pankreas erforderlich. Erwartungsgemäß konnte bei diesen Patienten, im Gegensatz zu Normalpersonen, kein Unterschied in der Insulinausschüttung nach oraler und intravenöser Verabreichung von Glucose festgestellt werden. Aus diesen Ergebnissen ist zu schließen, daß die Ähnlichkeit der Plasmainsulin-Veränderungen nach oraler und parenteraler Gabe von Glucose bereits auf einen frühen Schaden der exokrinen Pankreasfunktion hinweisen könnte. Man kann daraus die Folgerung ziehen, daß ein (hypothetischer) „Glucose receptor“ derβ-Zelle oder ihrer Oberflächenmembran mehr oder weniger unabhängig von exokrinem Pankreasgewebe und intestinalen Hormonen funktioniert. Andererseits scheint der „Entero-Rezeptor“ derβ-Zelle, der auf die insulinstimulierende Wirkung der intestinalen Hormone reagiert, mehr oder weniger abhängig zu sein von ausreichendem Vorhandensein intakten exokrinen Pankreasgewebes.
    Notes: Summary In 11 non-diabetic patients with clinical and laboratory evidence of chronic exocrine pancreatic insufficiency, the effect of intestinal hormones secretin and pancreozymin upon insulin secretion, blood sugar, free fatty acids and glycerol was studied and compared with the findings obtained in 30 normal volunteers. — In the patients suffering from exocrine pancreatic insufficiency the above mentioned enterohormones did not elicit any increase in serum insulin although insulin secretion after i.v. glucose loads was perfectly undisturbed. Obviously, the mediator inducing insulin release following secretin and pancreozymin in man depends on intact exocrine pancreatic tissue. As had been expected, no differences in the serum-insulin responses to oral and intravenous glucose, as found in normals, were established in these patients. From theses results it is inferred that similarity of plasma insulin changes after oral and parenteral glucose loads might hint at an early impairment of exocrine pancreatic tissue function. That implies, that a (hypothetical) “Glucose receptor” of theβ-cell or its surface works more or less independently of both the exocrine pancreatic tissue and the intestinal hormones. On the other hand, the “Entero-receptor” of theβ-cell responding to the insulin-stimulating action of intestinal hormones, such as secretin and pancreozymin, is likely to be more or less dependent upon sufficient amounts of intact exocrine pancreatic tissue.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...